A comparison of blood pressure in community pharmacies with ambulatory, home and general practitioner office readings: Systematic review and meta-analysis

Journal of Hypertension

Volumn 35, Issue 10, 2017, Pages 1919-1928

  Albasri, Ali ^a   O'Sullivan, Jack W ^a   Roberts, Nia W ^b   Prinjha, Suman ^a   McManus, Richard J ^a   Sheppard, James P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Ambulatory; blood pressure; clinic; general practitioner; home; hypertension; pharmacy

Indexed keywords

AMBULATORY MONITORING; BLOOD PRESSURE MONITORING; CLINICAL ASSESSMENT; CLINICAL PHARMACY; DIASTOLIC BLOOD PRESSURE; GENERAL PRACTITIONER; GENETIC HETEROGENEITY; GOLD STANDARD; HOME MONITORING; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; MANAGED CARE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; GENERAL PRACTICE; META ANALYSIS; PHARMACY; PHYSIOLOGY; PROCEDURES; STATISTICS AND NUMERICAL DATA;

BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; GENERAL PRACTICE; HUMANS; PHARMACIES;

EID: 85020395016     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000001443     Document Type: Review

References (34)

1. World Health Organization. A global brief on hypertension-silent killer, global public health crisis. Geneva, Switzerland: World Health Organization; 2013.
2. Department of Epidemiology and Public Health Unit. Survey for England Joint Health Surveys Unit. Leeds, UK: Health and Social Care Information Centre 2015. Available from: Http://content.digital.nhs.uk/catalogue/PUB16076/HSE2013-Sum-bklet.pdf. [Accessed 20 October 2016]
3. Public Health England. Tackling high blood pressure (presentation). London, UK: Public Health England; 2015. Available from https://www. gov.uk/guidance/high-blood-pressure-plan-and-deliver-effective-servi ces-and-treatment. [Accessed 20 October 2016]
4. Hobbs FDR, Bankhead C, Mukhtar T, Stevens S, Perera-Salazar R, Holt T, et al. Clinical workload in UK primary care: A retrospective analysis of 100 million consultations in England, 2007-2014. Lancet 2016; 387:2323-2330.
5. National Institute for Health and Care Excellence. Hypertension: Management of hypertension in adults in primary care. London, UK: NICE; 2011; CG127.
6. Wood S, Greenfield SM, Haque MS, Martin U, Gill PS, Mant J, et al. Influence of ethnicity on acceptability of method of blood pressure monitoring: A cross-sectional study in primary care. Br J Gen Pract 2016; 66:e577-e586.
7. Imai Y, Ohkubo T, Sakuma M, Tsuji II, Satoh H, Nagai K, et al. Predictive power of screening blood pressure, ambulatory blood pressure and blood pressure measured at home for overall and cardiovascular mortality: A prospective observation in a cohort from Ohasama, Northern Japan. Blood Press Monit 1996; 1:251-254.
8. Ohkubo T, Hozawa A, Nagai K, Kikuya M, Tsuji I, Ito S, et al. Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population: The Ohasama study. J Hypertens 2000; 18:847-854.
9. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. Blood Press 2013; 22:193-278.
10. Todd A, Copeland A, Husband A, Kasim A, Bambra C. The positive pharmacy care law: An area-level analysis of the relationship between community pharmacy distribution, urbanity and social deprivation in England. BMJ Open 2014; 4:e005764.
11. World Health Organisation. Pharmacy-based hypertension management model: Protocol and guidelines. Copenhagen, Denmark: World Health Organisation; 2005.
12. LloydsPharmacy. Blood pressure testing. Coventry, UK: LloydsPharmacy; 2015 ; Available from: Http://www.lloydspharmacy.com/en/info/blood-pressure-testing. [Accessed 20 October 2016].
13. Royal Pharmaceutical Society. Monitoring blood pressure-a quick reference guide. London, UK: Royal Pharmaceutical Society; 2011.
14. Sabater-Hernandez D, Azpilicueta I, Sanchez-Villegas P, Amariles P, Baena MI, Faus MJ. Clinical value of blood pressure measurement in the community pharmacy. Pharm World Sci 2010; 32:552-558.
15. Sabater-Hernandez D, de la Sierra A, Sanchez-Villegas P, Baena MI, Amariles P, Faus MJ. Magnitude of the white-coat effect in the community pharmacy setting: The MEPAFAR study. Am J Hypertens 2011; 24:887-892.
16. Sendra-Lillo J, Sabater-Hernandez D, Sendra-Ortola A, Martinez-Martinez F. Comparison of the white-coat effect in community pharmacy versus the physician's office: The Palmera study. Blood Press Monit 2012; 16:62-66.
17. Moher D, Liberati A, Tetzlaff J, Altman DG, Grp P. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. J Clin Epidemiol 2009; 62:1006-1012.
18. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011; 155:529-536.
19. Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc 2009; 172:137-159.
20. Aleman JAGV, Sanchez JM, Caro JLL, Hernandez ML. The ZANyCONTROL study. The role of the pharmacy. Rev Clin Esp 2008; 208:483-489.
21. Padwal RS, Townsend RR, Trudeau L, Hamilton PG, Gelfer M. Comparison of an in-pharmacy automated blood pressure kiosk to daytime ambulatory blood pressure in hypertensive subjects. J Am Soc Hypertens 2015; 9:123-129.
22. Botomino AMB, Ruf D, Bruppacher R, Hersberger KE. White coat effect and white coat hypertension in community pharmacy practice. Blood Press Monit 2005; 10:13-18.
23. Chambers LW, Kaczorowski J, O'Rielly S, Ignagni S, Hearps SJ. Comparison of blood pressure measurements using an automated blood pressure device in community pharmacies and family physicians' offices: A randomized controlled trial. CMAJ Open 2013; 1:E37-E42.
24. Chung CMHJ, Chang CH, Pan KL, Huang JT. Magnitude of the whitecoat hypertension in the community pharmacy. Exp Clin Cardiol 2014; 20:2909-2931.
25. Mutlu S, Sari O, Arslan E, Aydogan U, Doganer YC, Koc B. Comparison of ambulatory blood pressure measurement with home, office and pharmacy measurements: Is arterial blood pressure measured at pharmacy reliable-J Eval Clin Pract 2016; 22:40-45.
26. Divisón JAAL, Sanchisa C, Á lvarezb F, Carbayoa J, Carrióna J, Mart-nez-Navarroa E. Can or should blood pressure be measured at pharmacy offices-Aten Primaria 2001; 28:24-33.
27. Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011; 343:d4002.
28. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-560.
29. Onat A, Ceyhan K, Erer B, Basar O, Uysal O, Sansoy V. Systolic, diastolic, and pulse pressures as coronary risk factors in a population with low cholesterol levels: A prospective 10-year evaluation. Clin Cardiol 2003; 26:91-97.
30. Lichtenstein MJ, Shipley MJ, Rose G. Systolic and diastolic blood pressures as predictors of coronary heart disease mortality in the Whitehall study. Br Med J (Clin Res Ed) 1985; 291:243-245.
31. Clark CE, Horvath IA, Taylor RS, Campbell JL. Doctors record higher blood pressures than nurses: Systematic review and meta-analysis. Br J Gen Pract 2014; 64:e223-e232.
32. Hodgkinson J, Mant J, Martin U, Guo B, Hobbs FDR, Deeks JJ, et al. Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: Systematic review. BMJ 2011; 343:d3621.
33. NHS Choices. NHS pharmacy services explained. London, UK: NHS Choices; 2015; Available from: Http://www.nhs.uk/NHSEngland/AboutNHSservices/pharmacists/Pages/pharmacistsandchemists.aspx. [Accessed 20 October 2016].
34. Curtis L. Unit costs of health and social care. Personal Social Services Research Unit Kent; 2014.